Cargando…
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs), endogenous cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of (endo)cannabinoids. To date, two CBs, CB1 and CB2, have been characterized; however, orphan G-protein-coupled receptor GPR55 has...
Autores principales: | Pyszniak, Maria, Tabarkiewicz, Jacek, Łuszczki, Jarogniew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958360/ https://www.ncbi.nlm.nih.gov/pubmed/27486335 http://dx.doi.org/10.2147/OTT.S106944 |
Ejemplares similares
-
Percentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment
por: Pyszniak, Maria, et al.
Publicado: (2014) -
Anticancer effect of terpenes: focus on malignant melanoma
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2023) -
Synergy, Additivity and Antagonism between Esculetin and Six Commonly Used Chemotherapeutics in Various Malignant Melanoma Cell Lines—An Isobolographic Analysis
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2023) -
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management
por: Bouaziz, Jerome, et al.
Publicado: (2017) -
The Interplay between Cancer Biology and the Endocannabinoid System—Significance for Cancer Risk, Prognosis and Response to Treatment
por: Moreno, Estefanía, et al.
Publicado: (2020)